US

Brut gathers about $40 mln Series B

New York and Paris-based Brut, a global digital media brand for millennials and Gen Z, has raised about $40 million in Series B funding. Red River West and blisce led the round.

b8ta picks up $50 mln Series C

San Francisco and New York-based b8ta, a provider of retail-as-a-service, has secured $50 million in Series C funding. Evolution Ventures led the round.

Femtech startup Inne snags funding

Femtech startup Inne has secured 8 million euros in funding. Blossom Capital led the round with participation from other investors that included Monkfish Equity.

OMERS Ventures leads Series C round for Crunchbase

Crunchbase, a provider of private-company prospecting and research solutions, has secured US$30 million in Series C funding. OMERS Ventures led the round with participation from Emergence, Mayfield, Cowboy Ventures and Verizon. In addition to the funding, Michael Yang, managing partner at OMERS Ventures, will join Crunchbase's board of directors. This round brings Crunchbase's total funding to US$56.5 million. OMERS Ventures is the venture capital investment arm of OMERS, a Canadian pension fund.

TetraScience grabs $8 mln Series A

Boston-based TetraScience, a developer of cloud-based data integration platform for life sciences R&D, has raised $8 million in Series A funding. TetraScience's backers include Waters Corporation, Floodgate Capital, First Round Capital, Underscore VC, Founder Collective and Y Combinator.

Namogoo lands $40 mln Series C

Namogoo, a cybersecurity firm, has raised $40 million in Series C funding. Oak HC/FT led the round. In addition to the funding, Matt Streisfeld, a partner at Oak HC/FT, will join Namogoo's board of directors.

Tmunity Therapeutics inks $75 mln Series B

Philadelphia-based Tmunity Therapeutics, a biotherapeutics firm, has secured $75 million in Series B financing. Andreessen Horowitz led the round.

VC-backed Rallybio expands team with two new additions

Rallybio LLC, a biotech firm, has added Dr. Amanda Hayward and Lisa Sinclair to its team.

VC-backed Galvanize hires CRO

Galvanize named Pascal Van Dooren as chief revenue officer.

Kira Biotech attracts Series A

Australian immunology company Kira Biotech has secured A$20 million in Series A funding. OneVentures, IP Group and the Advance Queensland Business Development Fund led the round.